Q4 2023 · 13F-HR
TANG CAPITAL MANAGEMENT LLCholdings as filed
Filed 2024-02-14 · accession 0001214659-24-002878
$1.08B
Reported value
123
Positions
2023-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 60468T105 | MRTXEUR | MIRATI THERAPEUTICS INC | $91.5M | 8.46% | 1,558,059 | Common | SHARED |
| 45253H101 | IMGNEUR | IMMUNOGEN INC | $65.2M | 6.02% | 2,199,137 | Common | SHARED |
| 87650L103 | TARS | TARSUS PHARMACEUTICALS INC | $44.6M | 4.13% | 2,204,797 | Common | SHARED |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $42.1M | 3.89% | 3,440,345 | Common | SHARED |
| 53000N108 | LIANY | LIANBIO | $41.9M | 3.87% | 9,366,783 | Common | SHARED |
| 032724106 | ANAB | ANAPTYSBIO INC | $41.8M | 3.86% | 1,950,609 | Common | SHARED |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $33.6M | 3.10% | 1,137,107 | Common | SHARED |
| 30052C107 | EOLS | EVOLUS INC | $32.6M | 3.01% | 3,097,399 | Common | SHARED |
| 02155H200 | ALT | ALTIMMUNE INC | $30.9M | 2.86% | 2,750,000 | Common | SHARED |
| 45258D105 | IMCR | IMMUNOCORE HLDGS PLC | $27.7M | 2.56% | 405,600 | Common | SHARED |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $25.5M | 2.35% | 320,000 | Common | SHARED |
| 69366J200 | PTCT | PTC THERAPEUTICS INC | $24.8M | 2.29% | 900,000 | Common | SHARED |
| 38406L103 | — | GRACELL BIOTECHNOLOGIES INC | $22.0M | 2.03% | 2,191,417 | Common | SHARED |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $19.5M | 1.80% | 679,630 | Common | SHARED |
| 92243G108 | PCVX | VAXCYTE INC | $18.8M | 1.74% | 300,000 | Common | SHARED |
| 532457108 | LLY | ELI LILLY & CO | $17.5M | 1.62% | 30,000 | Common | SHARED |
| 649445103 | NYCBEUR | NEW YORK CMNTY BANCORP INC | $16.4M | 1.52% | 1,606,600 | Common | SHARED |
| 46116X101 | ITCIEUR | INTRA-CELLULAR THERAPIES INC | $15.8M | 1.46% | 220,000 | Common | SHARED |
| 07725L102 | ONC | BEIGENE LTD | $15.3M | 1.42% | 85,000 | Common | SHARED |
| 05337M104 | — | AVADEL PHARMACEUTICALS PLC | $15.2M | 1.41% | 1,079,528 | Common | SHARED |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $15.1M | 1.39% | 692,925 | Common | SHARED |
| H17182108 | CRSP | CRISPR THERAPEUTICS AG | $13.5M | 1.24% | 215,000 | Common | SHARED |
| 88369M101 | — | THESEUS PHARMACEUTICALS INC | $13.2M | 1.22% | 3,255,026 | Common | SHARED |
| 04683R106 | AVIR | ATEA PHARMACEUTICALS INC | $12.4M | 1.15% | 4,076,741 | Common | SHARED |
| 046353108 | AZNN | ASTRAZENECA PLC | $11.4M | 1.06% | 170,000 | Common | SHARED |
| 98985Y108 | ZYME | ZYMEWORKS INC | $11.4M | 1.06% | 1,100,000 | Common | SHARED |
| 37733W204 | GSK | GSK PLC | $11.1M | 1.03% | 300,000 | Common | SHARED |
| G5269C101 | — | KINIKSA PHARMACEUTICALS LTD | $10.5M | 0.97% | 600,000 | Common | SHARED |
| 23284F105 | CTMX | CYTOMX THERAPEUTICS INC | $10.2M | 0.94% | 6,550,000 | Common | SHARED |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $10.1M | 0.93% | 200,000 | Common | SHARED |
| 07373V105 | BEAM | BEAM THERAPEUTICS INC | $9.5M | 0.88% | 350,000 | Common | SHARED |
| 23282W605 | CYTK | CYTOKINETICS INC | $9.2M | 0.85% | 110,000 | Common | SHARED |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $8.8M | 0.81% | 70,000 | Common | SHARED |
| 413197104 | HRMY | HARMONY BIOSCIENCES HLDGS IN | $8.8M | 0.81% | 271,200 | Common | SHARED |
| 23257D103 | CBAYUSD | CYMABAY THERAPEUTICS INC | $8.3M | 0.76% | 350,000 | Common | SHARED |
| 462260100 | IOVA | IOVANCE BIOTHERAPEUTICS INC | $8.1M | 0.75% | 1,000,000 | Common | SHARED |
| 230031106 | CGEM | CULLINAN ONCOLOGY INC | $7.9M | 0.73% | 771,138 | Common | SHARED |
| 60770K107 | MRNA | MODERNA INC | $7.6M | 0.70% | 76,700 | Common | SHARED |
| 77313F106 | RCKT | ROCKET PHARMACEUTICALS INC | $7.5M | 0.69% | 250,000 | Common | SHARED |
| 38870X104 | GRPH | GRAPHITE BIO INC | $6.5M | 0.60% | 2,491,780 | Common | SHARED |
| 09077B104 | BCABGBP | BIOATLA INC | $6.2M | 0.57% | 2,524,076 | Common | SHARED |
| 49705R105 | KNTEUSD | KINNATE BIOPHARMA INC | $6.2M | 0.57% | 2,601,647 | Common | SHARED |
| 000899104 | ADMA | ADMA BIOLOGICS INC | $6.1M | 0.57% | 1,360,000 | Common | SHARED |
| 45826J105 | NTLA | INTELLIA THERAPEUTICS INC | $6.1M | 0.56% | 200,000 | Common | SHARED |
| 126600105 | CVBF | CVB FINL CORP | $6.1M | 0.56% | 300,000 | Common | SHARED |
| 92337C203 | VSTM | VERASTEM INC | $6.0M | 0.56% | 741,514 | Common | SHARED |
| G1110E107 | BHVN | BIOHAVEN LTD | $6.0M | 0.55% | 140,000 | Common | SHARED |
| 294628102 | HP5A | EQUITY COMWLTH | $5.8M | 0.53% | 300,000 | Common | SHARED |
| 29664W105 | ESPR | ESPERION THERAPEUTICS INC NE | $5.5M | 0.51% | 1,850,000 | Common | SHARED |
| 75974E103 | — | RENEO PHARMACEUTICALS INC | $5.3M | 0.49% | 3,330,000 | Common | SHARED |
| 67080N101 | NUVB | NUVATION BIO INC | $5.3M | 0.49% | 3,500,000 | Common | SHARED |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $5.2M | 0.48% | 504,242 | Common | SHARED |
| 090572207 | BIO | BIO RAD LABS INC | $5.2M | 0.48% | 16,000 | Common | SHARED |
| 457669307 | INSM | INSMED INC | $5.2M | 0.48% | 166,203 | Common | SHARED |
| 09203E105 | BDTX | BLACK DIAMOND THERAPEUTICS I | $5.1M | 0.47% | 1,803,200 | Common | SHARED |
| 05156V102 | AUPH | AURINIA PHARMACEUTICALS INC | $4.9M | 0.46% | 550,000 | Common | SHARED |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $4.9M | 0.46% | 2,000,000 | Common | SHARED |
| 923451108 | VBTX | VERITEX HLDGS INC | $4.9M | 0.45% | 210,000 | Common | SHARED |
| 09058V103 | BCRX | BIOCRYST PHARMACEUTICALS INC | $4.8M | 0.44% | 800,000 | Common | SHARED |
| 75082Q105 | — | RAIN ONCOLOGY INC | $4.6M | 0.43% | 3,850,513 | Common | SHARED |
| 09627Y109 | 2655787D | BLUEPRINT MEDICINES CORP | $4.6M | 0.43% | 50,000 | Common | SHARED |
| 902973304 | USB | US BANCORP DEL | $4.3M | 0.40% | 100,000 | Common | SHARED |
| 268158201 | DVAX | DYNAVAX TECHNOLOGIES CORP | $4.2M | 0.39% | 300,000 | Common | SHARED |
| 097702104 | BOLT1EUR | BOLT BIOTHERAPEUTICS INC | $4.1M | 0.38% | 3,652,244 | Common | SHARED |
| N90064101 | QURE | UNIQURE NV | $4.1M | 0.38% | 600,000 | Common | SHARED |
| 25056L103 | DSGN | DESIGN THERAPEUTICS INC | $3.9M | 0.36% | 1,480,675 | Common | SHARED |
| 14179K101 | CRGX | CARGO THERAPEUTICS INC | $3.7M | 0.34% | 160,544 | Common | SHARED |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $3.6M | 0.34% | 100,000 | Common | SHARED |
| 65487U108 | NKTX | NKARTA INC | $3.6M | 0.34% | 550,000 | Common | SHARED |
| 062540109 | BOH | BANK HAWAII CORP | $3.6M | 0.33% | 50,000 | Common | SHARED |
| 004225108 | ACAD | ACADIA PHARMACEUTICALS INC | $3.6M | 0.33% | 114,400 | Common | SHARED |
| 15673T100 | IPSC | CENTURY THERAPEUTICS INC | $3.5M | 0.33% | 1,066,440 | Common | SHARED |
| 00653A107 | ADAPY | ADAPTIMMUNE THERAPEUTICS PLC | $3.5M | 0.32% | 4,387,238 | Common | SHARED |
| 22053A107 | — | QUINCE THERAPEUTICS INC | $3.4M | 0.31% | 3,220,000 | Common | SHARED |
| 04335A105 | ARVN | ARVINAS INC | $3.3M | 0.30% | 80,000 | Common | SHARED |
| 48576A100 | — | KARUNA THERAPEUTICS INC | $3.2M | 0.29% | 10,000 | Common | SHARED |
| 427746102 | HRTX | HERON THERAPEUTICS INC | $3.1M | 0.29% | 1,850,000 | Common | SHARED |
| N44821101 | IFRX | INFLARX NV | $3.1M | 0.28% | 1,873,753 | Common | SHARED |
| 03237H101 | AMLX | AMYLYX PHARMACEUTICALS INC | $2.9M | 0.27% | 200,000 | Common | SHARED |
| 29251M106 | ENTA | ENANTA PHARMACEUTICALS INC | $2.8M | 0.26% | 300,000 | Common | SHARED |
| 04746L104 | — | ATHIRA PHARMA INC | $2.8M | 0.26% | 1,152,715 | Common | SHARED |
| 023111206 | — | AMARIN CORP PLC | $2.7M | 0.25% | 3,086,544 | Common | SHARED |
| 31189P102 | FATE | FATE THERAPEUTICS INC | $2.6M | 0.24% | 700,000 | Common | SHARED |
| 81750R102 | MCRB1EUR | SERES THERAPEUTICS INC | $2.5M | 0.23% | 1,792,888 | Common | SHARED |
| 702712100 | — | PASSAGE BIO INC | $2.4M | 0.22% | 2,400,000 | Common | SHARED |
| 294100102 | ENZB | ENZO BIOCHEM INC | $2.4M | 0.22% | 1,700,000 | Common | SHARED |
| 09609G100 | — | BLUEBIRD BIO INC | $2.3M | 0.22% | 1,700,000 | Common | SHARED |
| 82835W108 | SPRY | ARS PHARMACEUTICALS INC | $2.2M | 0.21% | 409,463 | Common | SHARED |
| 28106W103 | EDIT | EDITAS MEDICINE INC | $2.0M | 0.19% | 200,000 | Common | SHARED |
| 81768T108 | SFBS | SERVISFIRST BANCSHARES INC | $2.0M | 0.18% | 30,000 | Common | SHARED |
| 70465T107 | PDSB | PDS BIOTECHNOLOGY CORP | $2.0M | 0.18% | 400,000 | Common | SHARED |
| 87583X109 | TNGX | TANGO THERAPEUTICS INC | $2.0M | 0.18% | 200,000 | Common | SHARED |
| 28623U101 | — | ELEVATION ONCOLOGY INC | $2.0M | 0.18% | 3,667,600 | Common | SHARED |
| 55279B301 | LITS | MEI PHARMA INC | $1.9M | 0.17% | 326,084 | Common | SHARED |
| 372279109 | GNFTY | GENFIT S A | $1.8M | 0.17% | 479,441 | Common | SHARED |
| 00461U105 | ACRS | ACLARIS THERAPEUTICS INC | $1.8M | 0.17% | 1,753,335 | Common | SHARED |
| 88322Q108 | TGTX | TG THERAPEUTICS INC | $1.7M | 0.16% | 100,000 | Common | SHARED |
| 007002108 | TORCEUR | ADICET BIO INC | $1.7M | 0.15% | 876,352 | Common | SHARED |
| 01626L105 | — | ALIGOS THERAPEUTICS INC | $1.5M | 0.13% | 2,189,847 | Common | SHARED |
| N51517105 | 4PKB | LAVA THERAPEUTICS NV | $1.3M | 0.12% | 840,593 | Common | SHARED |
| 640268108 | NKTREUR | NEKTAR THERAPEUTICS | $1.3M | 0.12% | 2,348,109 | Common | SHARED |
| 015271109 | ARE | ALEXANDRIA REAL ESTATE EQ IN | $1.3M | 0.12% | 10,000 | Common | SHARED |
| 74019P108 | — | PRECISION BIOSCIENCES INC | $1.2M | 0.11% | 3,400,000 | Common | SHARED |
| 65443P102 | MASS | 908 DEVICES INC | $1.1M | 0.10% | 100,000 | Common | SHARED |
| 921659108 | VNDA | VANDA PHARMACEUTICALS INC | $1.0M | 0.10% | 248,190 | Common | SHARED |
| 00509G209 | ABOS | ACUMEN PHARMACEUTICALS INC | $948,077 | 0.09% | 246,895 | Common | SHARED |
| 90089L108 | TSPH | TUSIMPLE HLDGS INC | $877,800 | 0.08% | 1,000,000 | Common | SHARED |
| 38341P102 | GOSS | GOSSAMER BIO INC | $765,223 | 0.07% | 838,600 | Common | SHARED |
| 002120202 | ATYR | ATYR PHARMA INC | $664,299 | 0.06% | 471,134 | Common | SHARED |
| 87184Q206 | SYRS | SYROS PHARMACEUTICALS INC | $662,391 | 0.06% | 85,031 | Common | SHARED |
| 269796108 | EGRX | EAGLE PHARMACEUTICALS INC | $621,622 | 0.06% | 118,857 | Common | SHARED |
| 64131A105 | STIM | NEURONETICS INC | $580,000 | 0.05% | 200,000 | Common | SHARED |
| 858927106 | STEL | STELLAR BANCORP INC | $556,800 | 0.05% | 20,000 | Common | SHARED |
| 65343E108 | NXTCEUR | NEXTCURE INC | $533,431 | 0.05% | 467,922 | Common | SHARED |
| 60853G106 | MOLN | MOLECULAR PARTNERS AG | $417,990 | 0.04% | 100,000 | Common | SHARED |
| 89532M101 | TRVI | TREVI THERAPEUTICS INC | $402,000 | 0.04% | 300,000 | Common | SHARED |
| 98422E103 | XERS | XERIS BIOPHARMA HOLDINGS INC | $352,500 | 0.03% | 150,000 | Common | SHARED |
| 29479A108 | ERAS | ERASCA INC | $319,500 | 0.03% | 150,000 | Common | SHARED |
| 49372L100 | — | KEZAR LIFE SCIENCES INC | $290,534 | 0.03% | 306,665 | Common | SHARED |
| 29446K106 | EQ | EQUILLIUM INC | $289,200 | 0.03% | 400,000 | Common | SHARED |
| 816212104 | SELBUSD | CARTESIAN THERAPEUTICS INC | $275,760 | 0.03% | 400,000 | Common | SHARED |
| 81663L200 | WGS | GENEDX HOLDINGS CORP | $175,000 | 0.02% | 63,636 | Common | SHARED |
| 00444T209 | TLPH | ACELRX PHARMACEUTICALS INC | $143,325 | 0.01% | 195,000 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.